Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine-induced killer cells in 294 patients

OBJECTIVE: To examine the efficacy and safety of a sequential combination of chemotherapy and autologous cytokine-induced killer (CIK) cell treatment in triple-negative breast cancer (TNBC) patients. METHODS: A total of 294 post-surgery TNBC patients participated in the research from January 1, 2009...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuhan, Wang, Shuaibing, Yang, Beibei, Lu, Su, Du, Yiyi, Liu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713632/
https://www.ncbi.nlm.nih.gov/pubmed/31516755
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713632/
https://www.ncbi.nlm.nih.gov/pubmed/31516755
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0378

Ejemplares similares